European Commission logo
English English
CORDIS - EU research results
CORDIS

Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours

Deliverables

ESR research outputs (publications, patent applications and presentations at conferences) and products)

Report that will compile relevant information concerning the research outputs publications done patent applications obtained presentations carried out at conferences and products achieved by each ESR

Dissemination of Tumor Treg Taregting results and achievements to the Scientific Community and products

This report will compile all the actions urdertaken by project partners to disseminate at national and international levels the project results and achievements to the Scientific Community and Wider Public

Launch and management of the Tumor Treg Targerting website

General audience will be reached via the establishment of a project specific web-site. The web-site will make reference to the aims, the background of the project, and general as well as specific advances in the field of cancer therapy. Specific breakthrough achievements of the ESR's projects will be posted, which will regularly be updated with PDFs of publications, made available by 6 months post publication or earlier. Any press article and review articles will be available for download or upon request. ESRs will use the website to disseminate their projects. They will place short videos explaining in easily understable, non specialist language, their projects and further implications for the wider society. In addition, the web-site will be used to advertise the job offers during the recruitment period. The website will also contain special area for social media with the information that will appear on the project twitter, facebook, linkedin and Youtube.

Publications

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

Author(s): Ardaiz N, Gomar C, Vasquez M, Tenesaca S, Fernandez-Sendin M, Di Trani CA, Belsué V, Escalada J, Werner U, Tennagels N, Berraondo P.
Published in: Front Pharmacol., 2021, ISSN 1663-9812
Publisher: Frontiers Media S.A.
DOI: 10.3389/fphar.2020.591293

Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

Author(s): Bella Á, Arrizabalaga L, Di Trani CA, Cirella A, Fernandez-Sendin M, Gomar C, Russo-Cabrera JS, Rodríguez I, González-Gomariz J, Alvarez M, Teijeira Á, Medina-Echeverz J, Hinterberger M, Hochrein H, Melero I, Berraondo P, Aranda F.
Published in: Oncoimmunology, 2022, ISSN 2162-4011
Publisher: Landes Bioscience
DOI: 10.1080/2162402x.2022.2098657

Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy.

Author(s): Huang, Shuyu; van Duijnhoven, Sander M J; Sijts, Alice J A M; van Elsas, Andrea; Immunologie; dI&I RA-I&I I&I
Published in: Journal of Cancer Research and Clinical Oncology, Issue 5, 2020, ISSN 0171-5216
Publisher: Springer Verlag
DOI: 10.1007/s00432-020-03404-6

Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers

Author(s): Teijeira A, Migueliz I, Garasa S, Karanikas V, Luri C, Cirella A, Olivera I, Cañamero M, Alvarez M, Ochoa MC, Rouzaut A, Rodriguez-Ruiz ME, Sanmamed MF, Klein C, Umaña P, Ponz M, Bacac M, Melero I.
Published in: Theranostics, 2022, ISSN 1838-7640
Publisher: Ivyspring International Publisher
DOI: 10.7150/thno.63359

Isotype selection for antibody‐based cancer therapy

Author(s): N. Vukovic, A. Elsas, J. S. Verbeek, D. M. W. Zaiss
Published in: Clinical & Experimental Immunology, Issue 203/3, 2021, Page(s) 351-365, ISSN 0009-9104
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/cei.13545

INTERLEUKIN-12 MESSAGE IN A BOTTLE

Author(s): Cirella, A. Berraondo, P. Di-Trani, C.A. Melero, I.
Published in: Clin Cancer Res, 2020, ISSN 1078-0432
Publisher: American Association for Cancer Research
DOI: 10.1158/1078-0432.ccr-20-3250

Mouse IgG2a Isotype Therapeutic Antibodies Elicit Superior Tumor Growth Control Compared with mIgG1 or mIgE

Author(s): Vukovic N, Segués A, Huang S, Waterfall M, Sijts AJAM, Zaiss DM.
Published in: Cancer Res Commun, 2023, ISSN 2767-9764
Publisher: American Association for Cancer Research
DOI: 10.1158/2767-9764.crc-22-0356

Novel strategies exploiting interleukin-12 in cancer immunotherapy

Author(s): Cirella A, Luri-Rey C, Di Trani CA, Teijeira A, Olivera I, Bolaños E, Castañón E, Palencia B, Brocco D, Fernández-Sendin M, Aranda F, Berraondo P, Melero I. Novel strategies exploiting interleukin-12 in cancer immunotherapy
Published in: Pharmacology & Therapeutics, 2022, ISSN 0163-7258
Publisher: Pergamon Press
DOI: 10.1016/j.pharmthera.2022.108189

Advances in mRNA-based drug discovery in cancer immunotherapy.

Author(s): Di Trani CA, Fernandez-Sendin M, Cirella A, Segués A, Olivera I, Bolaños E, Melero I, Berraondo P.
Published in: Expert Opin Drug Discov., 2022, ISSN 1746-0441
Publisher: Informa Healthcare
DOI: 10.1080/17460441.2021.1978972

A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing

Author(s): Shuyu Huang, Aina Segués, David Lutje Hulsik, Dietmar M. Zaiss, Alice J.A.M. Sijts, Sander M.J. van Duijnhoven, Andrea van Elsas
Published in: Journal of Immunological Methods, Issue 483, 2020, Page(s) 112811, ISSN 0022-1759
Publisher: Elsevier BV
DOI: 10.1016/j.jim.2020.112811

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

Author(s): Angela Bella; Claudia Augusta Di Trani; Myriam Fernandez-Sendin; Leire Arrizabalaga; Assunta Cirella; Alvaro Teijeira; José Medina-Echeverz; Ignacio Melero; Pedro Berraondo; Fernando Aranda
Published in: Cancers, Issue 3, 2021, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13050963

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

Author(s): Shirley Tenesaca; Marcos Vasquez; Maite Alvarez; Itziar Otano; Myriam Fernandez-Sendin; Claudia Augusta Di Trani; Nuria Ardaiz; Celia Gomar; Angela Bella; Fernando Aranda; José Medina-Echeverz; Ignacio Melero; Pedro Berraondo
Published in: Journal for Immunotherapy of Cancer, Issue 1, 2021, ISSN 2051-1426
Publisher: BMJ publishing group
DOI: 10.1136/jitc-2020-001587

Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

Author(s): Fernandez-Sendin M, Di Trani CA, Bella A, Vasquez M, Ardaiz N, Gomar C, Arrizabalaga L, Ciordia S, Corrales FJ, Aranda F, Berraondo P.
Published in: Frontiers in immunology, 2021, ISSN 1664-3224
Publisher: Lausanne: Frontiers Media S.A., 2010-
DOI: 10.3389/fimmu.2020.620283

Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils

Author(s): Teijeira A, Garasa S, Ochoa MDC, Cirella A, Olivera I, Glez-Vaz J, Andueza MP, Migueliz I, Alvarez M, Rodríguez-Ruiz ME, Rouzaut A, Berraondo P, Sanmamed MF, Perez Gracia JL, Melero I
Published in: Eur J Immunol, 2021, ISSN 0014-2980
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/eji.202049029

Purification of murine immunoglobulin E (IgE) by thiophilic interaction chromatography (TIC)

Author(s): Natasa Vukovic, Salim Harraou, Sander M.J. van Duijnhoven, Dietmar M. Zaiss, Andrea van Elsas
Published in: Journal of Immunological Methods, Issue 489, 2021, Page(s) 112914, ISSN 0022-1759
Publisher: Elsevier BV
DOI: 10.1016/j.jim.2020.112914

A Human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes

Author(s): Vukovic, Natasa; Halabi, Samer; Russo-Cabrera, Joan Salvador; Blokhuis, Bart; Berraondo, Pedro; Redegeld, Frank A M; Zaiss, Dietmar M W; Afd Pharmacology; LS Immunologie; Pharmacology
Published in: VOLUME=298;ISSUE=8;STARTPAGE=1;ISSN=0021-9258;TITLE=Journal of Biological Chemistry, Issue 7, 2022, ISSN 0021-9258
Publisher: American Society for Biochemistry and Molecular Biology Inc.
DOI: 10.1016/j.jbc.2022.102153

Shortened hinge design of Fab x sdAb-Fc bispecific antibodies enhances redirected T-Cell killing of tumor cells

Author(s): Shuyu Huang; Aina Segués; Martin Waterfall; David Wright; Charlotte Vayssiere; Sander M. J. van Duijnhoven; Andrea van Elsas; Alice J. A. M. Sijts; Dietmar M. Zaiss
Published in: Biomolecules; Volume 12; Issue 10; Pages: 1331, Issue 1, 2020, ISSN 0171-5216
Publisher: Springer Verlag
DOI: 10.3390/biom12101331

Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies

Author(s): Aina Segués, Sander M.J. van Duijnhoven, Marc Parade, Lilian Driessen, Nataša Vukovic, Dietmar Zaiss, Alice J.A.M. Sijts, Pedro Berraondo, Andrea van Elsas
Published in: Journal of Immunological Methods, Issue 499, 2021, Page(s) 113173, ISSN 0022-1759
Publisher: Elsevier BV
DOI: 10.1016/j.jim.2021.113173

Opportunities and challenges of bi-specific antibodies

Author(s): Segués A, Huang S, Sijts A, Berraondo P, Zaiss DM
Published in: Int Rev Cell Mol Biol, 2022, ISSN 1937-6448
Publisher: Elsevier Inc.
DOI: 10.1016/bs.ircmb.2022.05.001

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available